Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of mFOLFOX6 with or without bevacizumab after resection of stage II/III colon cancer
2005-000331-14Phase 3Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Feb 2005
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bevacizumab, oxaliplatin, fluorouracil and folinic acid in colon adenocarcinoma (2 arms), sponsored by Cancer Trials Ireland. Primary endpoint: Disease-free survival. Started Feb 2005; status: completed.
02
Drugs
bevacizumaboxaliplatinfluorouracilfolinic acid
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on 2005-000331-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000331-14.